학술논문
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
Document Type
Article
Author
Source
In ESMO Open August 2021 6(4)
Subject
Language
ISSN
2059-7029